Fludarabine Export Market Intelligence: India's 64 Suppliers Shipping to 49 Countries — TransData Nexus 2026

Q: Who are the top fludarabine exporters from India?

The top fludarabine exporters from India are: 1. INTAS PHARMACEUTICALS LIMITED — $1.9M (64.3% market share); 2. AXA PARENTERALS LIMITED — $404.5K (14.0% market share); 3. UNITED BIOTECH PRIVATE LIMITED — $114.2K (4.0% market share); 4. BETA DRUGS LIMITED — $61.8K (2.1% market share); 5. LIFEON PHARMACEUTICALS — $33.0K (1.1% market share). Together they account for 85.6% of India's total fludarabine export value.

Q: What is the total export value of fludarabine from India?

The total export value of fludarabine from India is $2.9M USD, recorded across 387 shipment transactions from 64 active exporters to 49 destination countries. The average shipment value is $7.5K.

Q: Which countries import fludarabine from India?

India exports fludarabine to 49 countries worldwide. The top importing countries are: POLAND (18.0% share, $519.1K), NETHERLANDS (16.0% share, $462.2K), VENEZUELA (14.9% share, $431.0K), FRANCE (10.0% share, $287.4K), CANADA (6.9% share, $199.8K). These five markets account for 65.8% of total export value.

Q: What is the HS code for fludarabine exports from India?

The primary HS code for fludarabine exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of fludarabine exports from India?

The average unit price for fludarabine exports from India is $27.79 USD per unit, with prices ranging from $0.52 to $229.36 depending on formulation, packaging, and order volume. The total market is valued at $2.9M across 387 shipments.

Q: Which ports handle fludarabine exports from India?

The primary ports for fludarabine exports from India are AHEMDABAD AIR ACC (INAMD4) (20.4% of shipments), SAHAR AIR (17.6% of shipments), SAHAR AIR CARGO ACC (INBOM4) (14.0% of shipments), DELHI AIR (8.0% of shipments), AHEMDABAD AIR (6.2% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of fludarabine?

India is one of the world's leading exporters of fludarabine due to its large base of 64 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports fludarabine to 49 countries, demonstrating 25% global market coverage.

Q: What certifications do Indian fludarabine exporters need?

Indian fludarabine exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import fludarabine from India?

There are 130 registered buyers importing fludarabine from India, spread across 49 countries. The repeat buyer rate is 40.8%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top fludarabine supplier from India?

INTAS PHARMACEUTICALS LIMITED is the leading fludarabine exporter from India with a market share of 64.3% and total export value of $1.9M across 167 shipments. The top 5 suppliers together control 85.6% of total export value.

Suresh Sormare

Fludarabine

India Pharmaceutical Trade Intelligence

$2.9M64 Suppliers49 CountriesHS 30049049

ExportsIndia → POLAND18.0%India → NETHERLANDS16.0%

ImportsNETHERLANDS → India$230.8K UNITED STATES → India$5.9K

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: ACCORD HEALTHCARE

Fludarabine Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Fludarabine to the World

Between 2022 and 2026, India exported $2.9M worth of fludarabine across 387 verified shipments to 49 countries — covering 25% of world markets in the Advanced Oncology segment. The largest destination is POLAND (18.0%). INTAS PHARMACEUTICALS LIMITED leads with a 64.3% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Fludarabine export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Fludarabine export data snapshot — $2.9M · 64 exporters · 49 countriesTransData Nexus · Indian Customs Data

Top Fludarabine Exporters from India

64 active exporters · Ranked by export value

View all 64 →

Top Fludarabine Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	INTAS PHARMACEUTICALS LIMITED	$1.9M	167	9	64.3%
2	AXA PARENTERALS LIMITED

Top Countries Importing Fludarabine from India

49 destination markets · Ranked by import value

All 49 countries →

Top Countries Importing Fludarabine from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	POLAND	$519.1K	18.0%
2	NETHERLANDS	$462.2K	16.0%
3	VENEZUELA	$431.0K	14.9%
4	FRANCE	$287.4K	10.0%
5	CANADA	$199.8K	6.9%
6	UNITED KINGDOM	$189.4K	6.6%
7	ITALY	$133.1K	4.6%
8	SPAIN	$93.8K	3.2%
9	ALGERIA	$82.4K	2.9%
10	HUNGARY	$59.4K	2.1%

POLAND is India's largest fludarabine export destination, absorbing 18.0% of total exports worth $519.1K. The top 5 importing countries — POLAND, NETHERLANDS, VENEZUELA, FRANCE, CANADA — together account for 65.8% of India's total fludarabine export value. The remaining 44 destination countries collectively receive the other 34.2%, indicating a focused distribution strategy targeting key markets.

Who Supplies Fludarabine to India?

2 origin countries · Total import value: $236.7K

India imports fludarabine from 2 countries with a combined import value of $236.7K. The largest supplier is NETHERLANDS ($230.8K, 5 shipments), followed by UNITED STATES. All values are from Indian Customs (DGFT) import records.

Countries Supplying Fludarabine to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	NETHERLANDS	$230.8K	5	97.5%
2	UNITED STATES	$5.9K	3	2.5%

NETHERLANDS is the largest supplier of fludarabine to India, accounting for 97.5% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Fludarabine

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, fludarabine is approved for the treatment of B-cell chronic lymphocytic leukemia (CLL). The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for fludarabine, indicating a competitive generic market. The presence of 64 active Indian exporters underscores India's significant role in supplying fludarabine to the U.S. market. As of March 2026, there are no active FDA import alerts specifically targeting fludarabine, suggesting compliance with U.S. regulatory standards.

2EU & UK Regulatory Framework

In the European Union, fludarabine has received marketing authorization for the treatment of CLL. The European Medicines Agency (EMA) ensures that fludarabine products meet stringent quality, safety, and efficacy standards. Manufacturers exporting to the EU must comply with the EU's Good Manufacturing Practice (GMP) requirements, which are harmonized across member states. In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the authorization and monitoring of fludarabine, adhering to similar GMP standards as the EU.

3WHO Essential Medicines & Global Standards

Fludarabine is included in the WHO Model List of Essential Medicines, reflecting its importance in treating priority health conditions. The 24th edition of the list, published in September 2025, continues to feature fludarabine, emphasizing its critical role in oncology. This inclusion guides national health policies and procurement decisions worldwide. Fludarabine formulations are standardized in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality and efficacy across different markets.

4India Regulatory Classification

In India, fludarabine is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, fludarabine is not listed under the Drugs (Prices Control) Order (DPCO), and thus, no ceiling price has been established. For export purposes, the Directorate General of Foreign Trade (DGFT) requires a No Objection Certificate (NOC) for fludarabine, ensuring that domestic supply is not adversely affected by export activities.

5Patent & Exclusivity Status

The primary patents for fludarabine have expired, leading to the availability of generic versions and increased competition in the market. This has facilitated the entry of multiple manufacturers, including Indian exporters, into both domestic and international markets.

6Recent Industry Developments

In May 2025, the WHO Expert Committee on Selection and Use of Essential Medicines convened to update the Model List of Essential Medicines, reaffirming the inclusion of fludarabine in the 24th edition published in September 2025. This underscores the ongoing global recognition of fludarabine's essential role in cancer treatment.

In April 2025, the WHO unveiled a global repository for National Essential Medicines Lists (nEMLs), providing a centralized digital platform that includes fludarabine among other critical medicines. This initiative aims to enhance access to essential healthcare data and support policymakers and healthcare professionals worldwide.

These developments reflect the sustained importance of fludarabine in global health initiatives and the pharmaceutical industry's commitment to ensuring its accessibility and quality.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Fludarabine

Retail & reference prices across 9 markets vs. India FOB export price of $27.79/unit

Global Price Benchmark for Fludarabine across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	Data not available	USD	The U.S. Food and Drug Administration (FDA) maintains the Orange Book, which lists approved drug products and their therapeutic equivalence evaluations. However, specific pricing information is not provided in this resource.
United Kingdom	Data not available	GBP	The National Health Service (NHS) Drug Tariff outlines reimbursement prices for medications. While it includes various drugs, specific pricing for Fludarabine 500 mg tablets is not detailed in the publicly available sections.
Germany	Data not available	EUR	The European Medicines Agency (EMA) provides a list of nationally authorized medicinal products, including Fludarabine, as of March 2023. However, this list does not include specific pricing information. (ema.europa.eu)

Supply Chain Risk Assessment — Fludarabine

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Fludarabine, an antineoplastic agent, is primarily manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) heavily relies on Key Starting Materials (KSMs) sourced from China. This dependency is part of a broader trend where approximately 70% of India's API imports originate from China, underscoring a significant supply chain vulnerability.

The COVID-19 pandemic in early 2020 exposed the fragility of this reliance, as disruptions in Chinese manufacturing led to shortages and price volatility in essential APIs. In response, the Indian government launched the Production Linked Incentive (PLI) scheme in October 2024, aiming to bolster domestic production of critical APIs and KSMs. Despite these efforts, the pharmaceutical industry continues to face challenges in reducing its dependence on Chinese imports.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 reveals that five Indian exporters account for 85.6% of Fludarabine exports, with INTAS PHARMACEUTICALS LIMITED alone contributing 64.3% ($1.9 million). This high supplier concentration poses a significant single-source risk, as any disruption affecting these key exporters could severely impact global supply chains.

The PLI scheme, initiated in October 2024, aims to mitigate such risks by incentivizing the establishment of new manufacturing units for critical APIs and KSMs. While this initiative has led to the inauguration of two greenfield plants producing essential antibiotic components, its impact on diversifying Fludarabine production remains to be seen.

Access Complete Fludarabine Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 387 transactions across 49 markets.

Request Demo View Pricing

Frequently Asked Questions — Fludarabine Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top fludarabine exporters from India?

The leading fludarabine exporters from India are INTAS PHARMACEUTICALS LIMITED, AXA PARENTERALS LIMITED, UNITED BIOTECH PRIVATE LIMITED, and 7 others. INTAS PHARMACEUTICALS LIMITED leads with 64.3% market share ($1.9M). The top 5 suppliers together control 85.6% of total export value.

What is the total export value of fludarabine from India?

The total export value of fludarabine from India is $2.9M, recorded across 387 shipments from 64 active exporters to 49 countries. The average shipment value is $7.5K.

Which countries import fludarabine from India?

India exports fludarabine to 49 countries. The top importing countries are POLAND (18.0%), NETHERLANDS (16.0%), VENEZUELA (14.9%), FRANCE (10.0%), CANADA (6.9%), which together account for 65.8% of total export value.

What is the HS code for fludarabine exports from India?

The primary HS code for fludarabine exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Fludarabine

Fludarabine

Top Fludarabine Exporters from India

Top Countries Importing Fludarabine from India

Who Supplies Fludarabine to India?

Quick Facts

Related Advanced Oncology

Related Analysis

Need Details?

Regulatory Landscape — Fludarabine

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Fludarabine

Supply Chain Risk Assessment — Fludarabine

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Fludarabine Trade Intelligence

Frequently Asked Questions — Fludarabine Exports from India

Who are the top fludarabine exporters from India?

What is the total export value of fludarabine from India?

Which countries import fludarabine from India?

What is the HS code for fludarabine exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of fludarabine exports from India?

Which ports handle fludarabine exports from India?

Why is India a leading exporter of fludarabine?

What certifications do Indian fludarabine exporters need?

How many buyers import fludarabine from India?

What is the market share of the top fludarabine exporter from India?

Analysis Methodology